SS Innovations Telerobotic Surgery Milestone Signals Growing Viability of Remote Care

SS Innovations International's SSi Mantra system has enabled 195 telesurgeries, highlighting the potential for remote robotic surgery to expand access to specialized care worldwide.

AI Industry News Staff
••Healthcare
SS Innovations Telerobotic Surgery Milestone Signals Growing Viability of Remote Care

SS Innovations International (NASDAQ: SSII) has reached a significant milestone in telerobotic surgery, with its SSi Mantra surgical robotic system supporting 195 remote procedures as of September 28, 2026. The achievement underscores the growing viability of remote surgery, which could help address disparities in access to specialized surgical care, particularly in underserved regions. The procedures included cardiac operations performed across substantial geographic distances, demonstrating the system's capability to enable expert surgeons to operate on patients far from their physical location.

Beyond telesurgery, the company reported a 45% increase in its installed base to 244 systems across 12 countries. Cumulative surgical procedures using the platform have reached 14,503, and approximately 1,500 physicians have been trained on the system. These metrics suggest increasing adoption of the SSi Mantra platform, which is designed to make robotic surgery more affordable and accessible. Recent international expansion includes new robotic cardiac surgery programs in Colombia, Sri Lanka, and India, indicating growing global interest in the technology.

The implications of these developments are notable for the healthcare industry. Telerobotic surgery has the potential to reduce travel burdens for patients and enable timely interventions in areas lacking specialized surgeons. As communications technology advances, the feasibility of remote procedures improves, and SS Innovations is positioning itself to capitalize on this trend. The company is also pursuing U.S. FDA clearance and European Union CE marking, which would allow entry into additional markets and further validate its technology.

For investors, the progress highlights SS Innovations' efforts to expand its footprint in the competitive surgical robotics market. The company's focus on affordability and accessibility may differentiate it from competitors, particularly in emerging markets. Detailed information about the company's telesurgery developments is available in the full article at https://ibn.fm/S3TFq. SS Innovations International, headquartered in India but operating as a U.S. company, develops the SSi Mantra system and SSi Mudra instruments. More about the company can be found at SSInnovations.com. The latest news and updates relating to SSII are available in the company's newsroom at https://ibn.fm/SSII.

The announcement was distributed through TechMediaWire, a communications platform focused on technology companies. TechMediaWire is part of the Dynamic Brand Portfolio at IBN, which provides wire solutions via InvestorWire and other services. The platform offers editorial syndication to 5,000+ outlets and social media distribution to reach a broad audience. Full terms of use and disclaimers are available at https://www.TechMediaWire.com/Disclaimer.

Blockchain Registration

QR Code for Blockchain Registration